BioCentury | Aug 14, 2019
Distillery Therapeutics

Antihelminthic compound bithionol could treat MRSA infection

...bithionol could be repurposed to treat methicillin-resistant S. aureus (MRSA) infections. In bacterial growth assays, bithionol...
...Medical School, Boston, Mass. email: ausubel@molbio.mgh.harvard.edu CONTACT: Eleftherios Mylonakis, Brown University, Providence, R.I. email: emylonakis@lifespan.org Claire Quang Bithionol Brown...
BioCentury | Nov 9, 2016
Distillery Therapeutics

Hepatic

...pulmonary disease and chronic obstructive pulmonary disease (COPD). Southern Research Institute and Yale University have bithionol ...
BioCentury | Apr 11, 2011
Company News

Champions Oncology, BC Cancer Agency deal

...Ramot at Tel Aviv University Ltd. (Tel Aviv, Israel), the university's technology transfer arm; and bithionol...
BioCentury | Nov 23, 2009
Company News

Champions Biotechnology, Southern Research Institute, Yale University deal

...The institute and Yale granted Champions exclusive, worldwide rights to develop and commercialize bithionol to treat...
...combination using its Biomerk Tumorgraft technology. The institute and university, which identified the activity of bithionol...
Items per page:
1 - 4 of 4